4 results match your criteria: "Tianjin Institute of Respiratory Disease[Affiliation]"
Chin Med J (Engl)
January 2015
Division of Pulmonary Medicine, Tianjin Haihe Hospital; Tianjin Institute of Respiratory Disease, Tianjin 300350, China.
Background: Hemoptysis is a significant clinical entity with high morbidity and potential mortality. Both medical management (in terms of resuscitation and bronchoscopic interventions) and surgery have severe limitations in these patients population. Bronchial artery embolization (BAE) represents the first-line treatment for hemoptysis.
View Article and Find Full Text PDFChin Med J (Engl)
March 2013
Division of Pulmonary Medicine, Tianjin Haihe Hospital, Tianjin Institute of Respiratory Disease, Tianjin 300350, China.
Chin Med J (Engl)
March 2012
Division of Pulmonary Medicine, Tianjin Hai He Hospital, Tianjin Institute of Respiratory Disease, Tianjin 300350, China.
Pulmonary vein thrombosis is a rare disease and is usually represented as a complication of atrial fibrillation, pulmonary tumors, and lobectomy. Although it is a potentially life threatening condition, the venous disease is easy to misdiagnose because of the non-specific symptoms. In this article, we present a 30-year-old patient who suffered from pulmonary vein thrombosis without any causes.
View Article and Find Full Text PDFZhongguo Wei Zhong Bing Ji Jiu Yi Xue
August 2006
Tianjin Institute of Respiratory Disease, Tianjin Haihe Hospital, Tianjin 300350, China.
Objective: To evaluate the effectiveness of bronchoscopic lung volume reduction (BLVR) using one way flap device in sheep model of heterogeneous emphysema.
Methods: Six 6-month sheep (weight: 20-30 kg) were treated with localized papain instillations to generate heterogeneous emphysema, subsequently underwent BLVR using one way-flap device at subsegment. Lung functional residual capacity (FRC) was analyzed before and 8 weeks after operation.